Arjil Biotech Holding Company Limited

Yeh B Wu

Jir-Mehng Lo

Pei-Hsin Lin

Hui Ju Liang

Hao Chiang

Cheng F Huang

Hui-Ju Liang

Wei-Chung Chiou

Cheng Huang

The present invention pertains to anti-coronaviral compounds. The disclosure includes a method for preventing and/or treating a coronavirus infection through the inhibition of a cysteine protease in a virus, particularly SARS-COV-2. Also provided includes the composition/pharmaceutical composition for preventing and/or treating a coronavirus infection comprising any of the compounds, pharmaceutically acceptable salt thereof, or its mixture, and the use of the compounds.

Compounds and methods for prevention and treatment of coronavirus infections

The present invention pertains to a composition for preparing a medicament for preventing and/or treating a virus infection, especially a hepatitis B virus infection and/or a herpes simplex virus, and uses thereof.

Method and composition for inhibiting virus infection

The invention relates to a use of a compound for manufacturing a medicament for treating an allergic disease, wherein the compound is selected from the group consisting of ovatodiolide, 1'-acetoxychavicol acetate, zerumbone and combination thereof. Also provided is a method and a composition for treating an allergic disease.

Method for treating an allergic disease

Growing community of inventors

Hsinchu, Taiwan

Yeh B Wu